Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: The role of autophagy

Carcinogenesis

Volumn 17, Issue 8, 1996, Pages 1595-1607

  Bursch, Wilfried ^a   Ellinger, Adolf ^a   Kienzl, Harald ^a   Török, Ladislaus ^a   Pandey, Siyaram ^b   Sikorska, Marianna ^b   Walker, Roy ^b   Hermann, Rolf Schulte ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLADENINE; 4 HYDROXYTAMOXIFEN; ANTIESTROGEN; DNA FRAGMENT; ESTRADIOL; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; TAMOXIFEN;

APOPTOSIS; ARTICLE; AUTOPHAGY; BREAST CARCINOMA; CANCER CELL CULTURE; CELL DEATH; CELL NUCLEUS; CELL ULTRASTRUCTURE; CELL VACUOLE; CHROMATIN STRUCTURE; CONTROLLED STUDY; DNA DEGRADATION; DNA SYNTHESIS INHIBITION; DRUG CYTOTOXICITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0029741890     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.8.1595     Document Type: Article

References (59)

1. Wyllie, A.H., Kerr, J.F.R. and Currie, A.R. (1980) Cell death: the significance of apoptosis. Int. Rev. Cytol., 68, 251-300.
2. Cohen, J.J., Duke, R., Fadok, V. and Sellins, K. (1992) Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol., 10, 267-293.
3. Bursch, W., Oberhammer, F. and Schulte-Hermann R. (1992) Cell death by apoptosis and its protective role against disease. Trends Pharmacol. Sci., 13, 245-251.
4. Tenniswood, M.P., Guenette, R.S., Latkins, J., Mooibroek, M., Wong, P. and Welsh, J.-E. (1992). Active cell death in hormone-dependent tissues. Cancer Metastases Rev., 11, 197-220.
5. Dexter, T.M., Raff, M.C. and Wyllie, A.H. (1994) Death from inside out: the role of apoptosis in development, tissue homeostasis and malignancy. Phil. Trans. R. Soc. Biol. Sci., 345, 231-333.
6. Schulte-Hermann, R., Bursch, W. and Grasl-Kraupp, B. (1995) Role of active cell death (apoptosis) in liver biology and diseases. Prog. Liver Dis., XIII, pp. 1-35.
7. Gullino, P.M. (1980) The regression process in hormone-dependent mammary carcinomas. In Iacobelli, S., King, R.B.J., Lindner, R and Lippman, M.E. (eds), Hormones and Cancer. Raven Press, New York, NY, pp. 271-279.
8. Welsch, C.W. (1985) Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res., 45, 3415-3443.
9. Dickson, R.B., Thompson, E.W. and Lippmann, M.E. (1989) Hormones and breast cancer in vitro. Hum. Cell, 2, 219-230.
10. Russo, J., Gusterson, B.A., Rogers, A., Russo, I.H., Wellings, S.R. and van Zwieten, M.J. (1990) Comparative study of human and rat mammary tumorigenesis. Lab. Invest., 62, 244-278.
11. Freiss, G., Prébois, C. and Vignon, F. (1993) Control of breast cancer cell growth by steroids and growth factors: interactions and mechanisms. Breast Cancer Res. Treatment, 27, 57-68.
12. Nandi, S., Guzman, R.C. and Yang, J. (1995) Hormones and mammary carcinogenesis in mice, rats and humans: a unifying hypothesis. Proc. Natl Acad. Sci. USA, 92, 3650-3657.
13. Kyprianou, N., English, H.F., Davidson, N.E. and Isaacs, J.T. (1991) Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res., 51, 162-166.
14. Jordan, V.C. and Murphy, C.S. (1990) Endocrine pharmacology of antiestrogens as antitumor agents. Endocrine Rev., 11, 1152-1159.
15. Early Breast Cancer Trialists' Collaborative Group. (1992) Systematic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet, 339, 71-85.
16. Osborne, C.K., Coronado-Heinsohn, E.B., Hilsenbeck, S.G., McCue, B.L., Wakeling, A.E., McClelland, R.A., Manning, D.L. and Nicholson, R.I. (1995) Comparison of the effects of a pure steriodal antiestrogen with those of tamoxifen in a model human breast cancer. J. Natl Cancer Inst., 87, 746-750
17. Wakeling, A.E. (1995). Use of pure antiestrogens to elucidate the mode of action of oestrogens. Biochem. Pharmacol., 49, 1545-1549.
18. Van de Velde, P. Nique, F., Bouchoux, F. et al. (1994) RU 58 668, a new pure antiestrogen inducing a regression of human mammary carcinoma implanted in nude mice. J. Steroid. Biochem. Mol. Biol., 48, 187-196.
19. Bardon, S., Vignon, F., Montcourier, P. and Rochefort, H. (1987) Steroid receptor-mediated cytotoxicity of an antiestrogen and antiprogestin in breast cancer cells. Cancer Res., 47, 1441-1448.
20. Warri, A., Huovinen, R.L., Laine, A.M., Martikainen, P.M. and Härkönen, P.L. (1993) Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J. Natl Cancer Inst., 85, 1412-1418.
21. Huovinen, R., Wärri, A. and Collan, Y. (1993) Mitotic activity, apoptosis and TRPM-2 mRNA expression in DMBA-induced rat mammary carcinoma treated with antiestrogen toremifene. Int. J. Cancer, 55, 685-691.
22. Wilson, J.W., Wakeling, A.E., Morris, J.D., Hickman, J.A. and Dive, C. (1995) MCF-7 human mammary adenocarcinoma cell death in vitro in response to hormone-withdrawal and DNA damage. Int. J. Cancer, 61, 502-508.
23. Kerr, J.F.R., Wyllie, A.H. and Currie, A.R. (1972) Apoptosis. A basic biological phenomenon with wide-ranging implications in tissue kinetics. J. Cancer, 26, 239-157.
24. Schweichel, J.-U. and Merker, H.J. (1973) The morphology of various types of cell death in prenatal tissues. Teratology, 7, 253-266.
25. Clarke, P.H. (1990) Developmental cell death: morphological diversity and multiple mechanisms. Anat. Embryol., 181, 195-213.
26. Schwartz, L.M., Smith, S.W., Jones, M.E.E. and Osborne, B.A. (1993) Do all programmed cell deaths occur via apoptosis? Proc. Natl Acad. Sci. USA, 90, 980-984.
27. Zakeri, Z., Bursch, W., Tenniswood, M. and Lockshin, R.A. (1995) Cell death: programmed, apoptosis, necrosis, or other? Cell Death Differential., 2, 83-92.
28. Lockshin, R.A. and Williams, C.M. (1964) Programmed cell death. II. Endocrine potentiation of the breakdown of the intersegmental muscles of silkmoths. J. Insect. Physiol., 10, 643-649.
29. Beckingham-Smith, K. and Tata, J.R. (1976) Cell death. Are new proteins synthesized during hormone-induced tadpole tail regression? Exp. Cell Res., 100, 129-146.
30. Seglen, P.O. and Gordon, P.B. (1982) 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat heptocytes. Proc. Natl Acad. Sci. USA, 79, 1889-1892.
31. Labarca, C. and Paigen, K. (1988) A simple rapid and sensitive DNA assay procedure. Anal. Biochem., 102, 344-353.
32. Oberhammer, F., Bursch, W., Parzefall, W., Breit, P., Erber, E., Stadler, M. and Schulte-Hermann, R. (1991) Effect of transforming growth factor beta on cell death of cultured rat hepatocytes. Cancer Res., 51, 2478-2485.
33. Walker, P.R., Kokileva, L., LeBlanc, J. and Sikorska, M. (1993) Detection of initial stages of DNA degradation in apoptosis. BioTechniques, 15, 1032-1040.
34. Bergmeyer, H.U. (1970) Methoden der enzymatischen Analyse. Verlag Chemie, Weinheim, Germany.
35. Kienzl, H. (1992) Antiöstrogen-induzierter Zelltod in kultivierten humanen Mamma karzinomzellen (MCF-7). PhD Thesis, Formal- und Naturwissenschaftliche Fakultät der Universität Wien, Wien, Austria.
36. Wakeling, A.E. and Bowler, J. (1988) Novel antiestrogens without partial agonist activity. J. Steroid Biochem., 31, 645-653.
37. 2+ alone. FEBS Lett., 349, 385-391.
38. Walker, R., Pandey, S. and Sikorska, M. (1995) Degradation of chromatin in apoptotic cells. Cell Death Differential., 2, 97-104.
39. Oberhammer, F., Wilson, J.W., Dive, C., Morris, I.D., Hickman, J.A., Wakeling, A.E., Walker, P.R. and Sikorska, M. (1993) Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of intemucleosomal fragmentation. EMBO J., 12, 3679-3684.
40. Wyllie, A.H. (1980) Glucocorticoid-induces in thymocytes a nuclease-activity associated with the chromatin condensation of apoptosis. Nature, 284, 555-556.
41. Arends, M.J., Morris, R.G. and Wyllie, A.H. (1990) Apoptosis - the role of endonuclease. Am. J. Pathol., 136, 593-607.
42. Grenman, R., Laine, K.-M., Klemi, P.J., Grenman, S., Hayashida, D.J.S. and Joensu, H. (1991) Effects of the antiestrogen toremifene on growth of the human mammary carcinoma cell line MCF-7. Cancer Res. Clin. Oncol., 117, 223-226.
43. Etienne, M.C., Milano, G., Fische, J.L., Frenay,. M., Francois, E., Formento, J.L., Gioanni, J. and Namer, M. (1989) Tamoxifen metabolism: pharmacokinetic and in vitro study. Br. J. Cancer, 60, 30-35.
44. Wiseman, H. (1994) Tamoxifen: new membrane-mediated mechanisms of action and therapeutic advances. Trends Pharmocol. Sci., 15, 83-89.
45. Tuner, M.J., Fields, C.E. and Everman, D.B. (1991) Evidence for superoxide formation during hepatic metabolism of tamoxifen. Biochem. Pharmacol., 41, 1701-1705.
46. Han, X.I. and Liehr, J.G. (1992) Induction of covalent DNA adducts in rodents by tamoxifen. Cancer Res., 52, 1360-1363.
47. Sargent, L.M., Dragan, Y., Bahnhub, N., Wiley, J., Sattler, C., Schroeder, P., Sattler, G., Jordan, V. and Pitot, H. (1994) Tamoxifen induces hepatic aneuploidy and mitotic spindle disruption after a single in vivo administration to female Sprague-Dawley rats. Cancer Res., 4, 3357-3360.
48. Bursch, W., Lauer, B., Timmermann-Trosiener, I., Barthel, G., Schuppler, J. and Schulte-Hermann, R. (1984) Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis, 5, 453-458.
49. Levi-Montalcini, R. (1987) The nerve growth factor thirty-five years later. In Vitro Cell. Dev. Biol., 23, 227-283.
50. Kyprianou, N., English, H.F. and Isaacs, J.T. (1990) Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res., 50, 3748-3753.
51. Pfeifer, U. (1982) Kinetic and subcellular aspects of hypertrophy and atrophy. Int. Rev. Exp. Pathol., 23, 1-45.
52. Grasl-Kraupp, B., Ruttkay-Nedecky, R., Koudelka, H., Bukowska, K., Bursch, W. and Schulte-Hermann, R. (1995) In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis and autolytic cell death, a cautionary note. Henatology, 21, 1465-1468.
53. 2+ concentration and DNA fragmentation. Cancer Res., 52, 1342-6.
54. Collins, R.J., Harmon, B.K., Gobe, G.C. and Kerr, J.F.R. (1992) Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int. J. Radiat. Biol., 61, 451-453.
55. Sarkaria, J.N., Gibson, D.F., Jordan, V.C., Fowler, J.F., Lindstrom, M.J. and Mulcahy, R.T. (1993) Tamoxifen-induced increase in the potential doubling time of MCF-7 xenografts as determined by bromodeoxyuridine labeling and flow cytometry. Cancer Res., 53, 4413-4417.
56. Ignar-Trowbridge, D.M., Nelson, K.G., Bidwell, M.C., Curtis, S.W., Washburn, T.F., McLachlan, J.A. and Korach, S. (1992) Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc. Natl Acad. Sci. USA, 89, 4658-4662.
57. Parczyk, K., Madjno, R., Klotz, M. and Schneider, M.R. (1995) Proceedings of the 12th International Symposium of the Journal of Steroid Biochemistry and Molecular Biology, Berlin, Germany, 21-24 May, 1995.
58. Milligan, G., Bond, R.A. and Lee, M. (1995) Inverse agonism: pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol. Sci., 16, 10-13.
59. Left, P. (1995) The two-stage model of receptor activation. Trends Pharmacol. Sci., 16, 89-97.